IMMUNOREGULATORY VACCINE Russian patent published in 2018 - IPC A61K39/00 

Abstract RU 2650709 C2

FIELD: biotechnology.

SUBSTANCE: immune-regulatory vaccine comprising a first portion comprising at least an anti-CD32 molecule linked to a TLR9 ligand and a first peptidic alpha-helix, and a second portion with at least epitope and a second peptidic alpha-helix coiled to the first alpha-helix, as a result of which a super-helix is formed, said first and second portions being interconnected by the formation of said super-helix, said first and second alpha-helixes being two different helixes, and wherein said super-helix is a hetero-helix formed by said two different helixes. Also described is an immunotherapy method for the treatment of allergic diseases in a patient, comprising administering to said patient an effective amount of a vaccine, wherein in said vaccine said anti-CD32 molecule is directed against CD32a and CD32b. Kit for obtaining a vaccine is also described.

EFFECT: method of treating a subject is provided to cause anti-immunogen IgG transient immune response, preferably with a defined maximum IgG titer, induced after vaccination, followed by reduction in the titer by at least 30%, preferably by at least 40%, or by at least 50%, or by at least 60%, or by at least 70%, or by at least 80%, or by at least 90%, or 100% within 6 months after vaccination, comprising administering to said subject an effective amount of a vaccine comprising an immunogenic composition, comprising a first portion containing at least an anti-CD32 molecule, linked to a TLR9 ligand, and an immunogen that is linked to said first portion preferably by linkage or affinity binding.

19 cl, 12 dwg, 3 tbl, 18 ex

Similar patents RU2650709C2

Title Year Author Number
IMMUNOGENIC COMPOSITION, VACCINE COMPRISING SAME, KIT FOR PREPARING SAID COMPOSITION AND METHOD OF TREATING DISEASES ASSOCIATED WITH GASTRIN SECRETION PATHOLOGY 2014
  • Brume, Pol Kristofer
  • Dzhejkobs, Frederik Uilyam
  • Langer, Kristof
  • Myudde, Gert Kornelius
RU2664197C2
ANTIGEN TAU-PEPTIDES AND THEIR APPLICATION 2010
  • Smith Iii George Joseph
  • Wills Kenneth Nelson
  • Zhu Jeff Xianchao
RU2518291C2
IMMUNOSTIMULATING COMPOSITIONS 2016
  • Carpentier, Antoine
  • Banissi, Claire
RU2732118C2
IMMUNOGENS FOR VACCINATION AGAINST HIV 2013
  • Brande Kristian
  • Mote Pukhadas Beatris
  • Lyano Anuska
RU2648791C2
PCSK9 VACCINE 2010
  • Champion Brian Robert
  • Contillo Jr. Leonard Gabriel
  • Eisenbraun Michael Dale
  • Fraser James Downey
  • Hawkins Julie Jia Li
  • Merson James Richard
  • Pierce Brian Gregory
  • Qiu Xiayang
  • Ullah Jakir Hussain
  • Wyatt David Michael
RU2538162C2
PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE 2013
  • Van Chan I
RU2696566C2
CONJUGATES OF PEPTIDE Melan-A, VIRUS-LIKE PARTICLE ANALOGUE 2004
  • Bakhmann Martin F.
  • Manolova Vania
  • Mehjerink Ehdvin
  • Proba Karl G.
  • Shvarts Katrin
RU2351362C2
PROSTATE-ASSOCIATED ANTIGENS AND IMMUNOTHERAPEUTIC REGIMENS BASED ON VACCINES 2013
  • Binder, Joseph John
  • Cho, Helen Kim
  • Dermyer, Michael Robert
  • Jooss, Karin Ute
RU2737765C2
PROSTATE-ASSOCIATED ANTIGENS AND IMMUNOTHERAPY SCHEMES BASED ON VACCINES 2013
  • Binder Dzhozef Dzhon
  • Chou Khelen Kim
  • Dermier Majkl Robert
  • Joss Karin Yute
  • Pies Brajen Gregori
  • Ten Dzhojs Tsi
  • Tsaj Van To
RU2609651C2
PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF ALZHEIMER-TYPE DEMENTIA 2013
  • Wang, Chang Yi
RU2811687C2

RU 2 650 709 C2

Authors

Mudde Gert

Dates

2018-04-17Published

2013-07-02Filed